EQRx is done, sold for its cash.
The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
BOSTON — A novel small-diameter lead wire had a high level of success for delivery of implantable cardioverter-defibrillator (ICD) shocks and low complications, the LEADR
The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Medical toxicologist @RyanMarino warns his followers not to follow Chris
Three women were diagnosed with HIV after getting “vampire facial” procedures at an unlicensed New Mexico medical spa, the CDC said in a report last